Ramos, MD, PhD, discusses findings from cohort 4 of the phase 2 SunRISe-1 trial of TAR-200 in patients with high-risk, BCG-unresponsive NMIBC with papillary-only disease.

When the former Kate Middleton was diagnosed with cancer in 2024, there was much speculation about the state of her health. Catherine, Princess of Wales, has since shared that she completed ...